Evaluation of the Global Clinical Pipeline of Antibiotics and Nontraditional Bacterial Products

Presenter
  • C. Lepore
Session
Virtual 335 - AAR08 New Antimicrobial Agents (in vitro and in vivo Studies Prior to the Start of Clinical Therapeutic Studies/Pre-phase 2) - In vitro and In vivo study of new antimicrobials
Audio Upload

Previous ePoster
Pangenomic Analysis of Salmonella Oranienburg Serovar Isolated from River Water in Northwestern méXico

Next ePoster
Some Contributing Factors to Failures of Itn Malaria Control Strategy among Pregnant Women
Determining the Efficacy and Safety of Glycoside Hydrolases as a Dispersal Agent against Biofilm Infections
Characterizing Biofilm Formation of Escherichia coli and Shewanella oneidensis on Different Carbon-Foam Electrodes
Investigation of an Unknown Gene and Putative Sodium Sulfate Transporter’s Connection to a Hypervirulent Mutant of the Soft Rot Bacterium Pectobacterium Carotovorum
Two-step Algorithm Implementation Significantly Impacts Hospital C. difficile Reporting Rate
Enrichment of Hormone-Degrading Microorganism with Potential Bioengineering Applications in Small-Scale Wastewater Treatment Systems
An Analysis and Comparison of Micrococcus Luteus Isolates from Soil and Indoor Air
Phylogenomics and Comparative Genomics of New Groups of Halophilic Archaea and Bacteria from Hypersaline Soils
Determinants of Selfdisclosure of Human Immunodeficiency Virus Serostatus among People Living with Hiv Attending Antiretroviral Therapy Clinic of a Tertiary Hospital in Nigeria
Silver Nanoparticles by Plant Stevia rebaudiana: Green Synthesis, Characterization and Antibacterial Activity